Types of Scleroderma
Scleroderma refers to a widespread disease afflicting connective tissues. It can produce deleterious changes in internal organs, muscles, blood vessels and the skin. The symptoms of the two types of Scleroderma are quite diverse. They range from hair loss and skin hardening to breathing problems, heartburn and difficulties with swallowing in severe cases of diffuse Scleroderma, the internal organs can be fatally damaged.
The Types of Scleroderma
Scleroderma takes two primary forms. The first is known as limited Scleroderma. It’s also referred to as morphea Scleroderma. CREST is another descriptor for this condition.
While limited Scleroderma can be quite serious, especially when it contributes to pulmonary hypertension, symptoms are generally limited to the face and extremities. Join pain, skin hardening, red marks, and other symptoms are quite common.
Diffuse Scleroderma is the more serious of the two types of this disease. Also known as system-wide, the condition tends to progress much more quickly than limited Scleroderma and with greater negative impact.
Those who suffer from diffuse Scleroderma will often suffer from the same symptoms as those who have morphea Scleroderma diagnoses. However, they may often encounter problems with critical internal organs, including the heart, lungs and kidneys. Often those with diffuse conditions will suffer the same kind of skin-related symptoms over a larger area than those with a limited case of the disorder.
Obviously, any case of Scleroderma must be taken seriously. Both types are progressive, have serious symptoms and can be fatal. That being said, the prognosis for those with limited Scleroderma is better than it is for those with a system-wide manifestation
Causes and Cures for Scleroderma
Considering the seriousness of the condition and its relatively high frequency, it would be reasonable to assume that the cause of the malady was well-known and that effective treatment regimens were available. That’s not really the case, however.
The medical community isn’t prepared to offer a clear position regarding the causes of Scleroderma and treatments currently focus on the management of symptoms, not the elimination of the conditions themselves. However, there is a growing body of evidence suggesting that both types may be related to the body’s ability to handle toxicity and the resultant multiplication of microscopic pathogenic bacteria. This opens the door for natural treatment regimens that may be capable of producing real results for those diagnosed with Scleroderma.